Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sunniva Inc C.SNN

Alternate Symbol(s):  SNNVF

Healthcare Biotechnology Cannabis
Sunniva Inc. is a Canada-based company. The Company is not engaged in any business.


CSE:SNN - Post by User

Sunniva Inc > NEWS!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Post by BeerGeekon Mar 17, 2020 5:04pm
245 Views
Post# 30818923

NEWS!

NEWS!"Following the amendment, the purchase price will be settled with CAD $12.9 million in cash and CAD $7.1 million through the issuance of 3,566,687 Series C Convertible, redeemable preferred shares of CannaPharmaRx. Following the settlement of indebtedness of SMI at closing and the mortgage on the Okanagan Falls property, including the previously received CAD $1.9 million in deposits, net cash proceeds at closing to Sunniva are expected to be approximately CAD $7.3 million. The Company and CannaPharmaRx continue to work as expeditiously as possible to get the SMI Transaction completed."


WHOLE ARTICLE LINK

https://www.sunniva.com/newsroom/detail/100/sunniva-inc-announces-amended-terms-of-the-previously
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities